Skip to main content

Kwality Pharmac: Stock for Long-Term Investors

 KKwality Pharmac (KWAL) 300


SECTOR: Pharmaceuticals

STOCK TYPE: BSE - Equity

ADDRESS

Village Nagkalan,

Majitha Road,

Amritsar, Punjab - 143601


NSE

BSE

ISIN

-

539997

INE552U01010


RATE GROWTH

1 WEEK

-3.86%

1 MONTH

-0.58%

3 MONTHS

-35.21%

6 MONTHS

-51.81%

1 YEAR

28.59%

2 YEARS

-

3 YEARS

-

5 YEARS

574.16%

52 WEEKS LOW

222.2

50 WEEKS HIGH

1110..30


PAST PERFORMANCE



CORPORATE ACTIONS

DIVIDENDS

EX-DATE

DIVIDEND (RS.)

Jan, 2017

0.60

BONUS

ANNOUNCEMENT DATE

RATIO

5 sept, 2017

1:1




FINANCIAL STRENGTH


SALES(Cr.)

MAR 2022

MAR 2021

456.13

138



NET INCOME(Cr.)

MAR 2022

MAR 2021

1199.91

151.46



SHARE CAPITAL(Cr.)

MAR 2022

MAR 2021

10

10



RESERVE & SURPLUS(Cr.)

MAR 2022

MAR 2021

172

52



BASIC EPS (RS.)

MAR 2022

MAR 2021

115.70

14.86



DILUTES EPS (RS.)

MAR 2022

MAR 2021

115.70

14.86



NET BOOK VALUE/SHARE (RS.)

MAR 2022

MAR 2021

175.94

59.47


FACE VALUE

MAR 2022

MAR 2021

10

10



3 YRS CAGR SALES (%)

MAR 2022

MAR 2021

66.19

38.24



3 YRS CAGR NET PROFIT (%)

MAR 2022

MAR 2021

298.76

81.52


ROCE (%)

MAR 2022

MAR 2021

77.25

26.93




PROMOTER STOCK



Major PROMOTORS

NAME

HOLDING

Arora Family & HUF

54.45%





COMPARISON

DURATION - 1 YEAR

(A) NATIONALIZE BANK / POST

(B) INSURANCE (TATA AIA)

(C) Kwality Pharmaz

INTEREST

4-5%

INTEREST

7%

PAST PERFORMANCE

Dividend given in 2017

RISK

0%

RISK

0%


INVESTMENT

MIN: 5 Yrs

RISK

100%

(HIGH RISK HIGH GAIN

&

HIGH RISK HIGH LOSS)


INVESTMENT PLANNING

  • An investor can invest in the above table 33% in each block

  • An investor can invest in (A+B) 50% and in C 50%

  • Total investment in C (Benefit: Dividend + rate growth + bonus)



ANIL’S RESEARCH


  • Company profit jumped to 120 Cr. compared to 15 Cr. last year.

  • Sales jumped from 138 cr. to 456 cr. in 2022 compared to 2021

  • Reserve increased from 52 cr. to 172 cr. in 2022 compared to 2021

  • CAGR Sales 3 years increased from 38% to 66% 2022 compared to 2021

  • CAGR Profit 3 years increased from 81% to 298% 2022 compared to 2021

  • Due to the corona period of last two years pharma industry has grown fenonamily.

  • The Company has given last bonus in 2017 which is 1:1.

  • The company 52 week high is 1110 and 52 week low is 222 and the current price is 300 which is near the bottom rate and the monthly return almost stopped the negative trend. so, now pattern becomes rounding from bottom to top. so, a long-term investment company may cross 1100.

  • As sales, profit, reserve, EPS, BVPS and ROE all are jumping unexpectedly high.


Please don't forget to follow our blog to get the latest updates on a daily bases.

Comments

Popular posts from this blog

🌞upcoming ipo🌞

 CCo, name:   Magson retail &  distribution Ltd Issue  start date : 23rd june 2023 Issue close date : 27th june 2023 Lot size : 2000  Issue prise : rs 65 to rs 65. Co name: Essen speciality films Ltd Issue  start date : 23rd june 2023 Issue close date : 27th June 2023 Lot size : 1200  Issue prise : rs 101 to rs 107. Co name : Greenchef Appliances  Ltd Issue  start date : 23rd jun 2023 Issue close date : 27th  June 2023 Lot size : 1600  Issue prise : rs 82 to rs 87.

Bank nifty 31St aug 2023

 TToday Bank Nifty achive Target of 44600. Means buy prise 44044  & Target prise 44600 Means profit 506* 15( one lot future):7509  ( approximate profit in 4 days on  approximate investment of 60000). 👍👍👍👍👍